HF 1183 (see companion bill SF 1265) – Minnesota

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF1183&ssn=0&y=2021

Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found